Project Grant R42HG011219

Award Date 9/14/20
Completion Date 5/31/26
Dollars Obligated $2.4M
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
Ohio, USA
Similar Awards
This Project Grant award, provided by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) federal grant program, aims to establish an open-source ecosystem to repurpose decommissioned DNA sequencers as flexible automation platforms for biological research. The $299,756 award to the New York Genome Center, Inc. (NYGC) will fund the development of the PySeq open-source toolkit, which enables the use of outdated sequencing instruments in spatial...
This federal Project Grant award of $350,000 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of a neural network-accelerated DNA and RNA sequence processing node, called CLEDGESEQ, for use in field, clinical, and industrial settings. The project aims to create advanced sequence analysis and communication capabilities for edge applications, enabling cost-effective and scalable DNA/RNA...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $383,482 to Electronic Biosciences, Inc. to develop the SPINSEQ platform, an innovative RNA sequencing technology. The goal is to create a highly precise and accurate solution for transcriptomic and epitranscriptomic analysis that can overcome the limitations of existing RNA sequencing methods. Key focus areas include maintaining RNA integrity, ensuring accurate sequencing,...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program provides $306,860 to Mixedlcmedia LLC, a small disadvantaged business, to develop and evaluate a prototype ultra-low flow liquid chromatography platform based on their proprietary porous layer open-tubular (PLOT) and monolithic nanocolumn technologies. The goal is to create a commercialization-ready LC system that enables deep proteomic...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $361,069 to The Johns Hopkins University to develop new analytical methods and software tools for unsupervised analysis of multi-sample single cell genomic data. The project aims to address three key challenges: inferring temporal progression of sample phenotype from cross-sectional data, integrating data across samples and modalities, and enabling comparative analysis of...
Geometric Data Analytics Inc. received a $249,252 Project Grant award from the Department of Energy Office of Science on February 14, 2022 to develop cloud-based biological data preparation, tracking, and checking technologies for artificial intelligence applications. The grant was awarded under the Office of Science Financial Assistance Program (CFDA #81.049), which supports basic research to deliver scientific discoveries and tools that transform understanding of nature and advance U.S. energy...
This Cooperative Agreement award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $856,513 to optimize and integrate two computational and experimental approaches, CRISPRME and ABSOLVE-SEQ, into a comprehensive pipeline for assessing variant-associated off-target risks in genome editing therapeutics. The award aims to support Investigational New Drug (IND) applications by delivering standardized software modules, standard...
This $400,000 Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) aims to build a next-generation genomic data processing system that incorporates state-of-the-art systems design principles. The key innovations include: (1) improving cluster scheduling policy using workload characterization and an execution time predictor, (2) developing machinery for independently-scheduled genomic tasks with...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $902,046 to Data Driven Bioscience Inc. to perform analytical and clinical validation of the extended applications for their DuoSeq genomic profiling assay. DuoSeq is a novel approach that enables dual DNA and RNA sequencing from a single workflow to provide comprehensive molecular diagnostic readouts for blood cancers, including DNA mutations, copy number alterations,...
This Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) Program (CFDA 47.070) aims to build a next-generation genomic data processing system that incorporates state-of-the-art systems design principles. The $200,000 award, effective from October 1, 2024 to September 30, 2027, focuses on three key innovations: (1) improving cluster scheduling policies based on characterization of genomic workloads, (2) developing machinery...

SCIDAP: SCIENTIFIC DATA ANALYSIS PLATFORM - THE RECENT PROLIFERATION OF NEXT-GENERATION SEQUENCING (NGS) - BASED METHODS FOR THE ANALYSIS OF EXPRESSION, CHROMATIN AND PROTEIN-DNA INTERACTIONS HAS CREATED TREMENDOUS OPPORTUNITIES FOR GAINING INSIGHTS INTO BIOLOGY, HEALTH, AND DISEASE. HOWEVER, ANALYSIS OF THE DATA REQUIRES COMPUTATIONAL EXPERTISE THAT MANY BIOLOGISTS DO NOT POSSESS. HENCE, WHEN DEALING WITH GENOMICS DATA, MAJORITY OF BIOLOGISTS REQUIRE THE HELP OF BIOINFORMATICIANS EVEN FOR SIMPLE TASKS. THIS PLACES THESE EXCITING METHODS BEYOND THE REACH OF THE MAJORITY OF LIFE SCIENTISTS. THIS PHASE II PROPOSAL FROM DATIRIUM, LLC, A START-UP FROM CINCINNATI, OH FOLLOWS PHASE I PROJECT THAT RESULTED IN THE DEVELOPMENT OF A PROTOTYPE (MVP) OF SCIDAP (SCIENTIFIC DATA ANALYSIS PLATFORM), A NOVEL MULTI- OMICS USER-FRIENDLY DATA ANALYSIS PLATFORM THAT ALLOWS BIOLOGISTS TO ANALYZE THE DATA AND ENABLES COLLABORATION WITH BIOINFORMATICIANS. THE CURRENT PHASE II PROPOSAL DESCRIBES A PLAN TO CONTINUE SCIDAP DEVELOPMENT. THE KEY PROBLEM FOR CREATING USER-FRIENDLY DATA ANALYSIS PACKAGES IS THE DIFFICULTY IN ADDING NEW OR MODIFYING EXISTING PIPELINES: DUE TO THE TIGHT COUPLING BETWEEN PIPELINE AND USER INTERFACE THIS REQUIRED CHANGES AT ALL LEVELS OF SOFTWARE. UNFORTUNATELY, THE SAME LIMITATION EXISTS FOR ALL USER-FRIENDLY BIOINFORMATICS TOOLS. GIVEN THAT THERE ARE MORE THAN 150 NGS-BASED METHODS AND MANY WAYS TO PROCESS THE DATA, THIS EXPLAINS WHY A UNIVERSAL AND USER-FRIENDLY DATA ANALYSIS PLATFORM DOES NOT YET EXIST. WE HYPOTHESIZED THAT WE CAN CREATE A DATA ANALYSIS PLATFORM THAT IS BOTH UNIVERSAL AND USER-FRIENDLY BY INCLUDING INTERFACE INSTRUCTIONS INTO COMPUTATIONAL PIPELINES. PLATFORM WILL USE THESE INSTRUCTIONS TO CREATE A GRAPHICAL INTERFACE. SPECIFICALLY, WE ARE USING CONTAINERIZED PIPELINES DEVELOPED USING COMMON WORKFLOW LANGUAGE (CWL) MAKING OUR PIPELINES BOTH PORTABLE AND REPRODUCIBLE. ON TOP OF CWL, DATIRIUM DEVELOPED A SYSTEM OF CWL EXTENSIONS THAT ALLOWS TO DESCRIBE THE INPUTS AND OUTPUTS VISUALIZATIONS WITHIN THE CWL WORKFLOWS. IMPORTANTLY, OUR PLATFORM WILL INCREASE THE RIGOR OF COMPUTATIONAL ANALYSIS BY (I) MAKING THE ANALYSIS REPRODUCIBLE AND AUDITABLE BY BIOINFORMATICIANS DUE TO CWL PIPELINE PORTABILITY AND RECORDING EACH STEP OF THE ANALYSIS AS RESEARCH OBJECTS; (II) ENABLING COLLABORATION BETWEEN EXPERIMENTALISTS AND COMPUTATIONAL BIOLOGISTS BY PROVIDING BIOINFORMATICIANS WITH A WAY TO DIRECT ANALYSIS FLOW AND BIOLOGISTS WITH THE CONVENIENCE OF GUI; (III) INCLUDING OUT OF THE BOX PIPELINES WITH OPTIMIZED PARAMETERS AND ACTIONABLE QC METRICS THAT FLAG POSSIBLE ISSUES. IN THE FIRST AIM OF THIS PROPOSAL WE WILL DEVELOP A VERSION OF SCIDAP FOR USE ON ACADEMIC CLUSTERS AND COMMERCIAL CLOUDS. IN THE SECOND AIM, IN COLLABORATION WITH DR. SALOMONIS AT CCHMC, WE WILL ADOPT PIPELINES MIRNA, WGS/WXS AND SCMULTIOME DATA ANALYSIS. IN THE THIRD, WE WILL DEVELOP IMPROVEMENTS TO SCIDAP INTERFACE THAT WILL INCREASE SCIDAP FLEXIBILITY AND USABILITY FOR BIOINFORMATICIANS AND EXPERIMENTALISTS. SUCCESSFUL COMPLETION OF THIS PROJECT WILL PROVIDE THE RESEARCH COMMUNITY WITH A CUTTING EDGE, FLEXIBLE AND BIOLOGIST-FRIENDLY DATA ANALYSIS PLATFORM.

Posted 5/16/22, 12:00 AM